BSW Wealth Partners boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 6.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,556 shares of the medical equipment provider’s stock after buying an additional 90 shares during the period. BSW Wealth Partners’ holdings in Intuitive Surgical were worth $812,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the third quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently commented on ISRG. Evercore ISI raised their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday. CICC Research initiated coverage on shares of Intuitive Surgical in a report on Monday. They set a “neutral” rating and a $550.00 price objective on the stock. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, Robert W. Baird upped their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.
Insider Buying and Selling
In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,749 shares of company stock valued at $15,303,875. Company insiders own 0.90% of the company’s stock.
Intuitive Surgical Stock Up 0.1 %
Shares of NASDAQ:ISRG opened at $574.14 on Wednesday. The firm has a market capitalization of $204.50 billion, a PE ratio of 92.31, a P/E/G ratio of 5.19 and a beta of 1.39. The company has a 50-day moving average price of $548.00 and a two-hundred day moving average price of $506.12. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Trading Stocks: RSI and Why it’s Useful
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- What Does the Future Hold for Eli Lilly?
- Investing in the High PE Growth Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.